Impact of receptor changes on treatment of status epilepticus.
Goodkin
Howard R
HR
Department of Neurology, University of Virginia, Health Sciences Center, Charlottesville, Virginia 22908, USA.
Joshi
Suchitra
S
Kozhemyakin
Maxim
M
Kapur
Jaideep
J
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors; D004195:Disease Models, Animal; D004351:Drug Resistance; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D006801:Humans; D008297:Male; D010261:Paraoxon; D018408:Patch-Clamp Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000502:physiology; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D013226:Status Epilepticus / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000187:drug effects / Q000502:physiology
D002800:Cholinesterase Inhibitors; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D005680:gamma-Aminobutyric Acid; D010261:Paraoxon